Intellia Therapeutics(NTLA) - 2023 Q2 - Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2023 Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Ian Karp - SVP, IR and Corporate Communications John Leonard - President and CEO David Lebwohl - EVP and CMO Laura Sepp-Lorenzino - EVP and CSO Glenn Goddard - EVP and CFO Conference Call Participants Maury Raycroft - Jefferies Unidentified Analyst - RBC Capital Joseph Thome - TD Cowen Mary Kate - Bank of America Unidentified Analyst - Truist Securities Unidentified Analyst - Barclays De ...